Erratum: Converging evidence for central 5-HT effects in acute tryptophan depletion (Molecular Psychiatry (2012) 17, (121-123) DOI: 10.1038/mp.2011.106);Converging evidence for central 5-HT effects in acute tryptophan depletion

Molecular Psychiatry

Volumn 17, Issue 2, 2012, Pages 121-123

  Crockett, M J ^a,b   Clark, L ^b   Roiser, J P ^c   Robinson, O J ^d   Cools, R ^e   Chase, H W ^f   Den Ouden, H ^e   Apergis Schoute, A ^a,b   Campbell Meikeljohn, D ^g   Seymour, B ^h   Sahakian, B J ^a,i   Rogers, R D ^j   Robbins, T W ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UK   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e RADBOUD UNIVERSITY   (Netherlands)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; NEUROTOXIN; PLACEBO; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ACUTE STRESS; ACUTE TRYPTOPHAN DEPLETION; BEHAVIOR; COGNITION; CYCLIC POTENTIOMETRY; DEPRESSION; EMOTION; EPISODIC MEMORY; HUMAN; LETTER; METABOLIC DISORDER; MICRODIALYSIS; MOOD DISORDER; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAPHE NUCLEUS; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SOCIAL ISOLATION; VALIDITY;

EID: 84856210278     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.134     Document Type: Erratum

References (12)

1. Neumeister A. Psychopharmacol Bull 2003; 37: 99-115.
2. van Donkelaar EL, Blokland A, Ferrington L, Kelly PA, Steinbusch HW, Prickaerts J. Mol Psychiatry 2011; 16: 695-713.
3. Stancampano R, Melis F, Sarais L, Cocco S, Cugusi S, Fadda F. Am J Physiol 1997; 272(3 Part 2): R991-R994.
4. Moja EA, Cipolla P, Castoldi D, Tofanetti O. Life Sci 1989; 44: 971-976.
5. Cools R, Roberts AC, Robbins TW. Trends Cogn Sci 2008; 12: 31-40.
6. Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW et al. Neuropsychopharmacology 2010; 35: 1290-1301.
7. Dayan P, Huys QJ. Annu Rev Neurosci 2009; 32: 95-126.
8. Mendelsohn D, Riedel WJ, Sambeth A. Neurosci Biobehav Rev 2009; 33: 926-952.
9. Harrison BJ, Olver JS, Norman TR, Burrows GD, Wesnes KA, Nathan PJ. J Psychopharm 2004; 18: 32-40.
10. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW. Neuropsychopharmacology 2002; 26: 716-728.
11. Sharp T, Umbers V, Hjorth S. Neuropharmacology 1996; 35: 735-741.
12. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. J Cereb Blood Flow Metab 2010; 30: 1682-1706.